BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26268498)

  • 1. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
    Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
    Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
    Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
    Hu Q; Li F; Yang K
    PeerJ; 2024; 12():e17391. PubMed ID: 38784388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
    Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
    Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
    Biron VL; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis.
    O'Rorke MA; Ellison MV; Murray LJ; Moran M; James J; Anderson LA
    Oral Oncol; 2012 Dec; 48(12):1191-201. PubMed ID: 22841677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
    Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
    Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
    JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
    Melchers LJ; Mastik MF; Samaniego Cameron B; van Dijk BA; de Bock GH; van der Laan BF; van der Vegt B; Speel EJ; Roodenburg JL; Witjes MJ; Schuuring E
    Br J Cancer; 2015 Apr; 112(8):1349-57. PubMed ID: 25867270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.
    Annertz K; Rosenquist K; Andersson G; Jacobsson H; Hansson BG; Wennerberg J
    Acta Otolaryngol; 2014 Aug; 134(8):843-51. PubMed ID: 24930912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.
    Hama T; Tokumaru Y; Fujii M; Yane K; Okami K; Kato K; Masuda M; Mineta H; Nakashima T; Sugasawa M; Sakihama N; Yoshizaki T; Hanazawa T; Kato H; Hirano S; Imanishi Y; Kuratomi Y; Otsuki N; Ota I; Sugimoto T; Suzuki S
    Oncology; 2014; 87(3):173-82. PubMed ID: 25033838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
    Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
    Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.
    Hong AM; Ferguson P; Dodds T; Jones D; Li M; Yang J; Scolyer RA
    Oral Oncol; 2019 May; 92():33-39. PubMed ID: 31010620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.